<DOC>
	<DOCNO>NCT01140217</DOCNO>
	<brief_summary>The purpose study determine whether NEA TDS effective prevention pregnancy . The safety product also evaluate .</brief_summary>
	<brief_title>Efficacy Safety Study Norethindrone Acetate Transdermal Delivery System Contraception</brief_title>
	<detailed_description>An Open Label Study Evaluate Contraceptive Efficacy Safety Norethindrone Acetate Transdermal Delivery System .</detailed_description>
	<mesh_term>Norethindrone acetate</mesh_term>
	<mesh_term>Norethindrone</mesh_term>
	<criteria>Healthy female 1845 year Regular , consistent menstrual cycle 25 35 day Sexually active risk become pregnant History infertility Known contraindication progestogen administration Pap smear suggestive highgrade precancerous lesion ( ) Clinically significant deviation normal screening test exams</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>contraception</keyword>
	<keyword>pregnancy</keyword>
</DOC>